Compare ELTX & HOFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTX | HOFT |
|---|---|---|
| Founded | 2011 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.4M | 152.5M |
| IPO Year | 2014 | 1999 |
| Metric | ELTX | HOFT |
|---|---|---|
| Price | $2.89 | $13.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 992.3K | 58.3K |
| Earning Date | 05-12-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | ★ 39.29 | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $2,301,000.00 | ★ $278,139,000.00 |
| Revenue This Year | N/A | $17.37 |
| Revenue Next Year | N/A | $9.00 |
| P/E Ratio | ★ N/A | $138.70 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.66 | $8.62 |
| 52 Week High | $16.00 | $18.09 |
| Indicator | ELTX | HOFT |
|---|---|---|
| Relative Strength Index (RSI) | 34.51 | 42.32 |
| Support Level | $2.72 | $11.99 |
| Resistance Level | $5.38 | $15.97 |
| Average True Range (ATR) | 0.24 | 0.80 |
| MACD | 0.22 | -0.15 |
| Stochastic Oscillator | 3.95 | 26.60 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
Hooker Furnishings Corp is a designer, marketer, and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality, and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segments: Hooker Branded segment, Domestic Upholstery segment, and All Other. It generates the majority of its revenue from the Hooker Branded segment.